primaquine has been researched along with Peripheral Nerve Diseases in 2 studies
Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Though these drugs are generally well tolerated, they can result in potentially severe adverse effects." | 5.56 | Murphy's law in force: sequential adverse events encountered during the treatment of Pneumocystis pneumonia (cotrimoxazole-induced acute peripheral neuropathy and primaquine-induced methemoglobinemia). ( Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Saxena, P; Sehgal, IS, 2020) |
| " Though these drugs are generally well tolerated, they can result in potentially severe adverse effects." | 1.56 | Murphy's law in force: sequential adverse events encountered during the treatment of Pneumocystis pneumonia (cotrimoxazole-induced acute peripheral neuropathy and primaquine-induced methemoglobinemia). ( Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Saxena, P; Sehgal, IS, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saxena, P | 1 |
| Muthu, V | 1 |
| Dhooria, S | 1 |
| Sehgal, IS | 1 |
| Prasad, KT | 1 |
| Agarwal, R | 1 |
| Sahu, KK | 1 |
| Mishra, AK | 1 |
| Lal, A | 1 |
| Siddiqui, AD | 1 |
| George, SV | 1 |
2 other studies available for primaquine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Murphy's law in force: sequential adverse events encountered during the treatment of Pneumocystis pneumonia (cotrimoxazole-induced acute peripheral neuropathy and primaquine-induced methemoglobinemia).
Topics: Anti-Bacterial Agents; Antimalarials; Clindamycin; Dapsone; Drug Therapy, Combination; Female; Human | 2020 |
Methemoglobinemia: a challenge while managing pneumocystis jirovecii pneumonia.
Topics: Humans; Methemoglobinemia; New Zealand; Peripheral Nervous System Diseases; Pneumonia, Pneumocystis; | 2020 |